Literature DB >> 11308298

Membrane raft microdomains in chemokine receptor function.

S Mañes1, R A Lacalle, C Gómez-Moutón, G del Real, E Mira, C Martínez-A.   

Abstract

Cell chemotaxis requires the acquisition and maintenance of both spatial and functional asymmetry between initially equivalent cell parts. In leukocytes one becomes the leading edge and the other, the rear edge or uropod. The acquisition of this cell polarity is controlled by an array of chemoattractants, including those of the chemokine family. We propose that chemokine receptor activation in highly organized lipid raft domains is a major determinant for the correct localization of the signaling pathways leading to the cell asymmetries required for migration. The lateral organization imposed by membrane raft microdomains is discussed in the context of other chemokine receptor activities, such as its role as a human immunodeficiency virus (HIV) coreceptor. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308298     DOI: 10.1006/smim.2000.0306

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  21 in total

1.  Cytoskeleton-dependent membrane domain segregation during neutrophil polarization.

Authors:  S Seveau; R J Eddy; F R Maxfield; L M Pierini
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling.

Authors:  Xuanmao Jiao; Ning Zhang; Xuehua Xu; Joost J Oppenheim; Tian Jin
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.

Authors:  Nathalie Signoret; Lindsay Hewlett; Silène Wavre; Annegret Pelchen-Matthews; Martin Oppermann; Mark Marsh
Journal:  Mol Biol Cell       Date:  2004-12-09       Impact factor: 4.138

Review 4.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

5.  A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms.

Authors:  Amanda L Harrison; Martin L Olsson; R Brad Jones; Stephanie Ramkumar; Darinka Sakac; Beth Binnington; Stephen Henry; Clifford A Lingwood; Donald R Branch
Journal:  Glycoconj J       Date:  2010-06-26       Impact factor: 2.916

6.  Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

Authors:  Alexander M Cole; Teresa Hong; Lee Ming Boo; Tung Nguyen; Chengquan Zhao; Greg Bristol; Jerome A Zack; Alan J Waring; Otto O Yang; Robert I Lehrer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 7.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Flotillins are involved in the polarization of primitive and mature hematopoietic cells.

Authors:  Lawrence Rajendran; Julia Beckmann; Astrid Magenau; Eva-Maria Boneberg; Katharina Gaus; Antonella Viola; Bernd Giebel; Harald Illges
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

9.  Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells.

Authors:  Daniel K Hsu; Alexander I Chernyavsky; Huan-Yuan Chen; Lan Yu; Sergei A Grando; Fu-Tong Liu
Journal:  J Invest Dermatol       Date:  2008-10-09       Impact factor: 8.551

10.  CXCL12-induced partitioning of flotillin-1 with lipid rafts plays a role in CXCR4 function.

Authors:  Banabihari Giri; Vishwa D Dixit; Manik C Ghosh; Gary D Collins; Islam U Khan; Karen Madara; Ashani T Weeraratna; Dennis D Taub
Journal:  Eur J Immunol       Date:  2007-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.